The discovery group typically sourced isolated cells from two well-known vendors, but has often had challenges with accrual timelines as well as the post-thaw quality and viability of the cells.
The name of the client and their company could not be disclosed for this case study due to the sensitive nature of their research.
Study Parameters
- 30 healthy apheresis patients
- Match sets of monocytes and pan T-cells from the same patient
- 30 CD14+ monocytes, 20MM cells
- 30 CD3+ pan T-cells, 20MM cells
- Quick accrual timeline
